Inventor
MARAIS RICHARD
GB21 patents
⚠️ This page may combine multiple inventors who share the name “MARAIS RICHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL
5 patentsUS10995088B2May 4, 2021
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2 citations69
US10807974B2Oct 20, 2020
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2 citations69
US11608330B2Mar 21, 2023
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations59
US12060360B2Aug 13, 2024
Lysyl oxidase inhibitors
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations58
US11325915B2May 10, 2022
Lysyl oxidase inhibitors
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL1 citations58
CANCER RES CAMPAIGN TECH
4 patentsUS5728868AMar 17, 1998
Prodrugs of protein tyrosine kinase inhibitors
CANCER RES CAMPAIGN TECH119 citations97
US6025340AFeb 15, 2000
Surface expression of enzyme in gene directed prodrug therapy
CANCER RES CAMPAIGN TECH2 citations62
US6004550ADec 21, 1999
Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
CANCER RES CAMPAIGN TECH3 citations62
US5770731AJun 23, 1998
Improvements relating to prodrugs
CANCER RES CAMPAIGN TECH0 citations52
CANCER REC TECH LTD
3 patentsUS9120789B2Sep 1, 2015
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
CANCER REC TECH LTD7 citations83
US8912191B2Dec 16, 2014
Pyrido[2,3-B]pyrazin-8-substituted compounds and their use
CANCER REC TECH LTD8 citations83
US8383816B2Feb 26, 2013
Aryl-quinolyl compounds and their use
CANCER REC TECH LTD13 citations81
SPRINGER CAROLINE JOY
2 patentsCANCER RES TECH LTD
2 patentsUS9439893B2Sep 13, 2016
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
CANCER RES TECH LTD4 citations83
US9725447B2Aug 8, 2017
1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer
CANCER RES TECH LTD8 citations82
CANCER RESEARCH TECH LTD
2 patentsUS9820976B2Nov 21, 2017
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
CANCER RESEARCH TECH LTD1 citations62
US10167282B2Jan 1, 2019
1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer
CANCER RESEARCH TECH LTD0 citations50